Independent Portfolio Consultants’s Halozyme HALO Stock Holding History

Independent Portfolio Consultants’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$9K	Buy	+700	New	+$9.35K	﹤0.01%	729

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Independent Portfolio Consultants's HALO Position: Q2 2017 in Review

Independent Portfolio Consultants opened a new position in Halozyme (HALO) in Q2 2017: 700 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #729 among its holdings.

167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

Independent Portfolio Consultants held 700 shares of Halozyme worth $9K as of Q2 2017.
Halozyme was a new Independent Portfolio Consultants position in Q2 2017.
Halozyme made up ﹤0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #729 holding.
167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.